Rationale and design of the SPRING trail: effectivity and safety of Pfo closuRe vs medIcine in alleviatiNg migraine, a multicenter, randomized and open-label trail

期刊论文
出版模式：

开放获取
发表日期：

2024年4月5日

查看全文

Yang Zi-yang,
Li Hezhi,
Luo Dongling,
Wang Ximeng,
Zhang Caojin,
Chen Weibin,
Guo Tao,
Cui Tongtao,
Wang Zhanhang,
Xiong Zhaojun,
Gao Hanhua,
Lai Junxing,
Yuan Jie,
Chen Jianying,
Wang Xiaodong,
Liu Wei,
Zhang Hongwei,
Zhang Gangcheng,
Zheng Xuan,
Shen Qunshan,
Chen Xiaobin,
Xie Dujiang,
Zhang Wenqi,
Wang Zhongchao,
Wei Wenbin,
Zhou Yang,
Zhang Wei

摘要

Background

Migraine is a leading cause of disability worldwide. Several retrospective studies have suggested that the closure of the Patent Foramen Ovale (PFO) may provide relief from migraines. However, three randomized controlled trials did not meet their primary endpoints regarding migraine cessation, reduction in monthly migraine days, and responder rates.

Methods

The SPRING study is a multicenter, prospective, randomized, and open-label trial designed to compare the effectiveness and safety of PFO closure versus medication in the relief of migraines. The primary endpoint is the total cessation of migraines, as recorded in patient headache diaries during the follow-up period. Additional diagnostic tools include echocardiography with agitated saline contrast, transcranial Doppler, and routine laboratory measurements.

Conclusion

The SPRING trial aims to assess the effectiveness and safety of PFO closure versus medication in mitigating migraines in real-world settings. (Clinical Trails ID: NCT04946734).